Suppr超能文献

昂丹司琼注射液的药物研发

Pharmaceutical development of ondansetron injection.

作者信息

Leak R E, Woodford J D

机构信息

Glaxo Group Research Ltd., Ware, Hertfordshire, U.K.

出版信息

Eur J Cancer Clin Oncol. 1989;25 Suppl 1:S67-9.

PMID:2533902
Abstract

Ondansetron injection is an aqueous solution containing ondansetron base as the hydrochloride dihydrate. The pH of the injection was selected to achieve good physical and chemical stability. The shelf life is 3 years when stored below 30 degrees C, protected from light. Ondansetron injection may be diluted for administration by slow intravenous injection or infusion and is compatible with several intravenous infusion fluids. In addition, specific concentrations of cisplatin, 5-fluorouracil, carboplatin, etoposide, ceftazidime, cyclophosphamide and doxorubicin are compatible when administered via a giving set delivering ondansetron by infusion.

摘要

昂丹司琼注射液是一种含有作为二水合盐酸盐的昂丹司琼碱的水溶液。选择该注射液的pH值以实现良好的物理和化学稳定性。在30摄氏度以下避光保存时,保质期为3年。昂丹司琼注射液可通过缓慢静脉注射或输注进行稀释以便给药,并且与几种静脉输液相容。此外,当通过输送昂丹司琼进行输注的给药装置给药时,特定浓度的顺铂、5-氟尿嘧啶、卡铂、依托泊苷、头孢他啶、环磷酰胺和多柔比星是相容的。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验